Ottawa partner David Schwartz will be in attendance as a speaker at the 18th International Pharmaceutical Patent Term Extensions Forum, in Munich, Germany.
David, along with leading in-house IP counsel, patent attorneys, representatives from multi-jurisdiction patent offices and policy authorities from around the globe, will share insights on the complexities of SPCs and other types of patent extensions. Attendees will gain comprehensive knowledge at the forefront of patent protection.
David’s presentation, “Understanding how the SPC System has changed through the CETA Agreement” will explore Canada’s agreement, through CETA, to make a number of important changes to intellectual property protection for pharmaceutical patentees in order to bring Canadian practice more in line with European practice. David will discuss the practical implementation of the SPC system to improve patent term extension success:
- Analysing Bill C-30’s amendment of the Canadian Patent Act on how to apply and enforce an SPC for pharmaceutical companies
- Determining the criteria for SPC eligible patents and its relation to:
- Medical ingredients
- Combination of medical ingredients
- Determining the rules for eligible patents whereby there are multiple patents subject to SPC
The C5 Group, comprising The Canadian Institute, American Conference Institute and C5 in Europe, is a leading global events and business intelligence company. C5’s goal is to help clients drive operational excellence, accelerate growth and deliver business value.
For more information on C5, click here.
Smart & Biggar is Canada's largest firm practising exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. As leaders in intellectual property and technology law Smart & Biggar has been serving clients for over a century.